G. Vascular function in rats with adenineinduced chronic renal failure. Am J Physiol Regul Integr Comp Physiol 302: R1426 -R1435, 2012. First published April 18, 2012 doi:10.1152/ajpregu.00696.2011The aim of the present study was to characterize the function of resistance arteries, and the aorta, in rats with adenine-induced chronic renal failure (A-CRF). Sprague-Dawley rats were randomized to chow with or without adenine supplementation. After 6 -10 wk, mesenteric arteries and thoracic aortas were analyzed ex vivo by wire myography. Plasma creatinine concentrations were elevated twofold at 2 wk, and eight-fold at the time of death in A-CRF animals. Ambulatory systolic and diastolic blood pressures measured by radiotelemetry were significantly elevated in A-CRF animals from week 3 and onward. At death, A-CRF animals had anemia, hyperphosphatemia, hyperparathyroidism, and elevated plasma levels of asymmetric dimethylarginine and oxidative stress markers. There were no significant differences between groups in the sensitivity, or maximal response, to ACh, sodium nitroprusside (SNP), norepinephrine, or phenylephrine in either mesenteric arteries or aortas. However, in A-CRF animals, the rate of aortic relaxation was significantly reduced following washout of KCl (both in intact and endothelium-denuded aorta) and in response to ACh and SNP. Also the rate of contraction in response to KCl was significantly reduced in A-CRF animals both in mesenteric arteries and aortas. The media of A-CRF aortas was thickened and showed focal areas of fragmented elastic lamellae and disorganized smooth muscle cells. No vascular calcifications could be detected. These results indicate that severe renal failure for a duration of less than 10 wk in this model primarily affects the aorta and mainly slows the rate of relaxation. chronic kidney disease; endothelial function; vascular smooth muscle cells; hypertension; mesenteric arteries; aorta PATIENTS WITH CHRONIC KIDNEY disease (CKD) are at increased risk of cardiovascular (CV) disease and in dialysis patients CV mortality rates are at least 10-to 20-fold higher than in the general population (5). The risk increases already when glomerular filtration rate (GFR) falls below 60 ml·min Ϫ1 ·1.73m
PATIENTS WITH CHRONIC KIDNEY disease (CKD) are at increased risk of cardiovascular (CV) disease and in dialysis patients CV mortality rates are at least 10-to 20-fold higher than in the general population (5) . The risk increases already when glomerular filtration rate (GFR) falls below 60 ml·min Ϫ1 ·1.73m
Ϫ2
(6) and a majority of CKD patients die from CV disease before developing end-stage renal disease (25) . The pathophysiological mechanisms causing the increase in CV risk in CKD patients are in many cases associated with comorbidity, such as primary hypertension, diabetes mellitus, hypercholesterolemia, and established atherosclerotic disease (5, 26) . However, the risk of CV death is markedly elevated also in children and young adults with CKD, although these patients often lack comorbidity (20) . Also, the causes of CV death are different in CKD patients compared with in the general population with an excess of sudden cardiac deaths (5) . Arterial abnormalities in patients with end-stage renal disease are typically characterized by increased stiffness and medial calcifications, which may develop in the absence of atherosclerosis and are associated with alterations in mineral and bone metabolism (32) . Both experimental and clinical studies have shown that endothelial function is impaired in CKD (1, 9, 14 -16, 36 -37) . In addition, vascular smooth muscle cells (VSMCs) undergo maladaptive changes in response to abnormalities in mineral metabolism that develop in CKD as GFR falls (28) . Taken together, observations in CKD patients clearly demonstrate that reduced GFR is a powerful independent risk factor for CV events and death (6, 33) . In addition, arterial abnormalities in these patients are atypical and differ from those in patients with normal kidney function, suggesting that pathophysiological mechanisms specifically related to decreased renal function are involved.
The main objective of the present study was to investigate the effects of chronic renal failure (CRF) on the functions of resistance arteries (second-order mesenteric arteries) and the thoracic aorta and to examine whether these vascular beds were affected differently. For this purpose, we chose the model of adenine-induced CRF (A-CRF) in rats as it produces more pronounced reductions in GFR compared with the more commonly used model of 5/6 nephrectomy, and as animals develop metabolic abnormalities closely resembling those observed in uremic patients (11, 13, 18 -19, 22, 24) . In addition, we wanted to examine arterial blood pressure (BP) by radiotelemetry during the development of renal failure in this model, as BP per se has major effects on arterial integrity.
METHODS

General Procedures
Ninety-six male Sprague-Dawley rats (Harlan, Horst, The Netherlands) weighing ϳ300 g were used and housed in rooms with a controlled temperature of 24 -26°C and a 12:12-h dark-light cycle. Chronic renal failure was produced by feeding animals with chow containing adenine using a similar protocol as others (11, 13, 18 -19, 22, 24) . Adenine is metabolized to 2,8-dihydroxyadenine, which is crystallized in tubular fluid leading to chronic tubulointerstitial injury, renal insufficiency, and metabolic abnormalities characteristic of CRF. In pilot studies, we observed that animals eating adeninecontaining chow had a reduced food intake and lost weight and hence controls were pair-fed.
At study start (i.e., day one of the study), all animals were randomized to, and provided with, standard pelleted rat chow containing adenine (adenine-induced CRF [A-CRF], n ϭ 49) or identical chow without adenine (pair-fed controls, n ϭ 47). The chow (R34, Lantmännen, Kimstad, Sweden) contained 0.63% phosphorous, 0.74% calcium, 0.53% potassium, and 0.22% sodium. The concentration of adenine in the chow was 0.5% for the first 3 wk followed by 0.3% for 2 wk and 0.15%, thereafter, until studies were terminated. The concentration of adenine in the chow was gradually reduced to avoid marked reductions in body weight and rapid development of terminal renal failure. Rats had free access to tap water throughout the experiment, and water intake was measured weekly. Chemicals were from Sigma (St. Louis, MO) if not stated otherwise. All experiments were approved by the regional ethics committee in Gothenburg.
Protocols
Protocol A, analyses of arterial BP by radiotelemetry. Eighteen rats were anesthetized with isoflurane and equipped with radiotelemetry transmitters for conscious BP and heart rate monitoring, as described previously (12) . Transmitters were implanted at least 7 days prior to first measurements. The telemetry transmitter catheter (outside diameter 0.76 mm; Data Sciences International, St. Paul, MN) was positioned into the abdominal aorta about 1 cm below the renal arteries and glued into position. The transmitter was secured to the abdominal wall with sutures. Data were collected and analyzed using Dataquest ART Version 3.1 (Data Science International). The BP signal was corrected for electronic offset, i.e., the average of one measurement outside the animal before implantation and one after explantation. Offset values greater than Ϫ10 or ϩ10 mmHg were excluded. Four out of 18 animals were excluded from analyses due to weak transmitter signal, unacceptable offset, or surgical complications leaving eight A-CRF animals and six controls in the study.
Arterial BP and heart rate were measured during 24 h at baseline, i.e., ϳ1 wk prior to study start, and at weeks 1, 3, 5, and 7 following study start. Presented data are average values of 24-h measurements.
Protocol B, ex-vivo analyses of vascular function using wire myograph. For these experiments, 39 A-CRF and 39 pair-fed controls were included. In a subset of animals, blood was sampled from the tail vein for plasma creatinine analysis at 2, 4, and 6 wk after study start. Experiments were performed 6 -10 wk after study start [56 Ϯ 10 days vs. 58 Ϯ 10 days in A-CRF group and controls, respectively, P ϭ not significant (n.s.)] with the exception of a subgroup of animals in which specifically aortic relaxation rate in response to vasodilator agonists ACh and sodium nitroprusside (SNP) were analyzed 8 -12 wk after study start [72 Ϯ 13 days vs. 71 Ϯ 16 days in A-CRF animals (n ϭ 9) and controls (n ϭ 8), respectively, P ϭ n.s.]. Animals were killed by decapitation, and second-order branches of the superior mesenteric artery or the thoracic aorta were excised for analyses by wire myograph (see above). Free-flowing trunk blood was collected and examined in a blood gas analyzer (ABL 725; Radiometer, Copenhagen, Denmark) for analyses of hemoglobin, bicarbonate, and sodium concentrations. Heparin-plasma was obtained following centrifugation (5,000 rpm for 10 min) and was stored at Ϫ20°or Ϫ80°C until analyzed. The heart, kidneys, and left tibia were excised, cleaned, and weighed, and tibia length was measured. Second-order branches of the superior mesenteric artery or the descending thoracic aorta were excised and cleaned while kept in cold (4°C) physiological salt solution (PSS) gassed with 95% O 2 and 5% CO2. Segments of mesenteric arteries (2-mm length) and aortic rings (2-3 mm) were mounted in a multiwire myograph system (model 620M; Danish Myo Technology, Aarhus, Denmark). Equilibration and normalization procedures were performed in warm (37°C) gassed PSS, as previously described (21) . The normalization procedure was used to set the vessels to a circumference close to where they produce maximal active tension.
The composition of PSS was (in mM): 119 NaCl, 4. 
Mesenteric Arteries
For these experiments, 11 A-CRF and 10 control animals were used. Vessel segments were stimulated three times (2-3 min) with norepinephrine (NE, 10 M) on top of 125 mM KCl (NE-KPSS) followed by one stimulation with KCl only. Cumulative concentration-response relations to NE (8 ϫ 10 Ϫ8 to 10 Ϫ5 M) were obtained. Thereafter arteries were submaximally precontracted with NE (70 -80% of Emax) before concentration-response relations for ACh (6 ϫ 10 Ϫ9 to 5 ϫ 10 Ϫ6 M) were determined. Subsequently, a second ACh curve was carried out in the presence of either vehicle, the nitric oxide synthase inhibitor N -nitro-L arginine-methyl ester hydrochloride (L-NAME, 300 M) or L-NAME together with the cyclooxygenase inhibitor indomethacin (3 M). Arteries were preincubated with these substances for 15 min before administering ACh. Finally, a concentration-response curve for SNP was made (1 ϫ 10 Ϫ9 to 1 ϫ 10 Ϫ3 M).
Intact Thoracic Aortas
Study A. Aortas from 26 animals (n ϭ 13 per group) were subjected to two consecutive contractions with KCl (125 mM) and one contraction by phenylephrine (PE; 100 nM) before cumulative concentrationresponse relations to PE (10 Ϫ11 to 10 Ϫ5 M) were obtained. EC80 values were calculated for each ring. Rings were then precontracted with their own calculated EC 80 values before relaxation curves for ACh (10 Ϫ9 to 10 Ϫ5 M) and SNP (10 Ϫ12 to 10 Ϫ4 M) were constructed. Study B. Experiments were performed in 9 A-CRF animals and 8 controls. Aortas were activated twice with KCl (85 mM). Rings were then precontracted with PE (100 nM) followed by administration of ACh (10 M) and SNP (1 M), and the time course of vascular relaxation was specifically investigated.
Endothelium-Denuded Thoracic Aortas
Experiments were performed in 6 A-CRF animals and eight controls, and specifically, the rates of contraction and relaxation were investigated. To remove the endothelium, rings were perfused with 200 l PSS containing 0.1% Triton X-100 (VWR International AB, Sweden) before mounting as described previously (30) . Denuded aortas were then activated with two consecutive contractions using 85 mM KCl and one contraction with PE (100 nM). Rings that had more than a 10% response to ACh (10 M) were discarded.
Calculations
Maximal responses to agonists (E max) were expressed as a percentage of the last NE-KPSS stimulation in mesenteric arteries and the final KCl stimulation in aortic rings. EC50, i.e., the concentration of agonist that produces a half-maximal effect, was calculated using nonlinear regression analysis. Rates of vascular contraction were determined from responses to the final administration of KCl during the start-up procedure and were calculated from the maximal slope of force. The rate was corrected for maximal generated force and expressed in percent of the maximal response per second (%/s). The time course of vascular relaxation was analyzed following washout of KCl with PSS during the start-up procedure, or in response to ACh or SNP, and the area under the curve (AUC) for the initial 50% reduction in force was calculated. Wall tension (T) was calculated as F/2l, where F is force and l is the length of the vascular segment and active media stress (⌬) was calculated as ⌬T/w where ⌬T is active wall tension and w is media thickness (see Histological Analyses).
Histological Analyses
Mesenteric arteries and aortic rings were immersion fixed in 4% neutrally buffered formaldehyde (Histolab Products AB, Gothenburg, Sweden) at the end of myograph experiments. All vessels were embedded in paraffin using routine techniques and 4-m-thick transverse sections were prepared and stained with hematoxylin and eosin, or von Kossa staining for the visualization of tissue calcifications. BioPix iQ 2.0 imaging software (Gothenburg, Sweden) was used for measuring cross-sectional areas of vessel lumen and the intima-media on hematoxylin-and-eosin-stained sections. In the aorta, media thickness was calculated by obtaining the lumen and lumenϩintima-media radii assuming a circular vessel shape. In mesenteric arteries, media thickness was measured directly (BioPix iQ 2.0) on opposite walls at three locations between the position of the two myograph wires. Arterial calcifications and medial abnormalities consisting of fragmentation of elastic lamellae and disorganized VSMCs were scored as either present or absent. All measurements and scorings were made by an investigator blinded for treatment group.
Biochemical Analyses
Plasma concentrations of creatinine, potassium, calcium, and phosphate were determined by a Modular P800 Cobas C 701/502 analyzer (Roche/Hitachi, Roche Diagnostics, Mannheim, Germany). Creatinine was measured by a photometric-enzymatic assay. Intact parathyroid hormone (PTH) was analyzed by an enzyme-linked immunosorbent assay (ELISA, Immutopics, San Clemente, CA). Analyses of 1,25-dihydroxyvitamin D 3 and plasma renin activity (PRA, both from DiaSorin, Stillwater, MN) and aldosterone (Siemens, Deerfield, IL) were performed by radioimmunoassay kits.
Concentrations of L-arginine and asymmetric (ADMA) and symmetric (SDMA) dimethylarginine in plasma were measured with HPLC, as described previously (31), using modified chromatographic separation conditions (4) . For all analytes, the intraassay and interassay coefficients of variation were Ͻ2% and Ͻ4%, respectively.
Total (free and protein-bound) plasma malondialdehyde (MDA) was measured in duplicate by HPLC and fluorescence detection after alkaline hydrolysis and reaction with thiobarbituric acid, as described previously (35) . The intrarun and interrun variations were 3.5% and 8.7%, respectively.
Plasma levels of 8-hydroxy-2-deoxyguanosine (8-OHdG) were determined by adding 40 l of 25 nM internal standard ( 15 N5 8-OHdG, Buchem, Apeldoorn, The Netherlands) and 0.3 ml of 4% phosphoric acid to 0.5 ml plasma. The analytes were then extracted using Oasis Mixed-Mode Anion Exchange cartridges (3 cc/60 mg; Waters, Milford, MA), as described before (2) . The extracted plasma samples were separated at a flow rate of 0.45 ml/min on a high-srength silica T3 column (1.8 m, 2.1 ϫ 100 mm; Waters, Milford, MA) using a gradient of milliQ water and methanol containing 0.1% acetic acid and were measured on an AB Sciex API 5000 triple quadrupole mass spectrometer (AB Sciex Technologies, Toronto, Canada) in positive-ion multiple-reaction monitoring acquisition mode using transition 284.2 to 168.2 m/z as a quantifier ion. The concentration of 8-OHdG was calculated using Analyst 1.5.2 software (AB Sciex) by comparison with a calibration curve of five standards in the range of 0.1-5.0 nM 8-OHdG containing the same amount of internal standard as the plasma samples. Intra-assay and inter-assay CVs were 5.8% and 7.2%, respectively.
Data Analyses and Statistics
All values are expressed as means Ϯ SD. DAQFactory Software (AzeoTech, Ashland, OR) was used for data sampling from myography experiments, and data were then analyzed using IGOR Pro (WaveMetrics, Portland, OR). Differences between means were analyzed using repeated-measures ANOVA or paired or unpaired Student's t-test where appropriate, and a significance level of 5% was used. Bonferroni correction was used to correct for multiple comparisons where appropriate. Chi-square test was used for categorical data. Calculations of EC 50 values and AUCs and all statistical analyses were performed with GraphPad Prism v. 5.03 (San Diego, CA).
RESULTS
Body Weight and Water Intake
There were no statistically significant differences between A-CRF animals and controls in body weight (Fig. 1A, Table 1 ) or food intake (data not shown) throughout the study period. A-CRF rats showed a transient reduction in body weight predominantly during the first week after study start and began to gain weight after about 3 wk (Fig. 1A) . Water intake was approximately twofold greater in A-CRF rats vs. controls throughout the study period (Fig. 1B , P Ͻ 0.001). A-CRF rats showed no obvious abnormalities in general behavior, and no spontaneous deaths occurred during the study. In addition, A-CRF rats did not appear edematous and no ascites or pleural effusions were observed after death.
Arterial Pressure and Heart Rate
Results of 24-h measurements of arterial pressure and heart rate by radiotelemetry are summarized in Fig. 2 . Animals with A-CRF developed increases in SBP and DBP that were evident 3 wk after study start ( Fig. 2A) . After 7 wk, SBP was 141 Ϯ 8 vs. 121 Ϯ 10 mmHg, and DBP was 98 Ϯ 9 vs. 82 Ϯ 10 mmHg, in A-CRF animals and controls, respectively. Repeated-measures ANOVA revealed statistically significant interactions between the within-subjects factor time and the between-subjects factor group (A-CRF or control) for both pulse pressure and heart rate ( Fig. 2, B and C) .
Organ Weights and Plasma Analyses
Kidney weight was clearly elevated in A-CRF rats (Table 1) , and macroscopically, these kidneys were markedly swollen and grayish in color with a granular surface, as previously described (38) . Left ventricular weight was significantly elevated in A-CRF rats vs. controls (Table 1) , whereas right ventricular weight was not significantly altered (data not shown). Blood hemoglobin levels (Table 1) and hematocrit (36.2 Ϯ 4.1 vs. 49.7 Ϯ 1.6%, P Ͻ 0.001) were significantly decreased in the A-CRF group.
Plasma creatinine concentrations were markedly elevated (Ϸ8-fold) in A-CRF animals vs. controls at the time of ex-vivo studies (Table 1) . Plasma creatinine levels were approximately doubled in A-CRF animals at 2 wk and continued to increase thereafter (Fig. 3) . Plasma potassium and aldosterone levels were significantly elevated, whereas PRA was clearly reduced, in A-CRF animals ( Table 1) . Rats with A-CRF showed abnormalities in mineral metabolism characteristic of CRF, i.e., elevated levels of plasma phosphate and PTH, and decreased concentrations of 1,25-dihydroxyvitamin D 3 , vs. controls (Table 1) . Plasma concentrations of potassium, phosphate, and calcium were somewhat elevated in controls compared with expected values in healthy animals. This could be explained by cell lysis, as plasma was derived from free-flowing trunk blood following decapitation, as described by others (27) .
Plasma levels of ADMA and SDMA were significantly elevated in A-CRF animals by approximately twofold, and four-fold, respectively, vs. controls (Table 2 ). There was no statistically significant difference between groups in L-arginine concentrations (Table 2) . Plasma levels of MDA and 8-OHdG were significantly increased in A-CRF animals ( Table 2) .
Myograph Experiments
Mesenteric arteries. There were no statistically significant differences between groups in media thickness or in maximal wall tension or media stress produced by NE or NE-KPSS Fig. 2 . Systolic (SBP) and diastolic blood pressure (DBP) (A), pulse pressure (B), and heart rate (C) measured in conscious animals by radiotelemetry (see METHODS) . Data are average values of ambulatory 24-h measurements. Arrows indicate the time point of randomization of rats to adenine-containing chow or normal control diet. For SBP and DBP, repeated-measures ANOVA showed statistically significant effects of between-subjects factor group (i.e., A-CRF vs. controls) P Ͻ 0.01; within-subjects factor time P Ͻ 0.01; and a group ϫ time interaction P Ͻ 0.01. For pulse pressure and heart rate, there was a statistically significant effect of time P Ͻ 0.05, and a group ϫ time interaction P Ͻ 0.05, whereas between group effects were not statistically significant. n ϭ 6 for controls and n ϭ 8 for A-CRF animals. Values are expressed as means Ϯ SD. Values are expressed as means Ϯ SD. Data from pair-fed control rats (controls) and animals with adenine-induced chronic renal failure (A-CRF) at the time of ex vivo studies (see METHODS). Biochemical analyses were performed on trunk blood collected from decapitated animals. BW, body weight; KW, kidney weight; LVW, left ventricular weight; Hb, hemoglobin; P, plasma; PRA, plasma renin activity; PTH, parathyroid hormone. n ϭ 15-24 per group. For PRA, PTH, 1,25-dihydroxyvitamin D3, and aldosterone, n ϭ 6 -11 per group. Significant differences, **P Ͻ 0.01 and ***P Ͻ 0.001.
( Table 3 ). The contractile response to NE was not significantly different between groups (Fig. 4A, Table 4 ).
There were no statistically significant differences between controls and A-CRF animals in EC 50 and E max for either ACh or SNP (Fig. 5, A and B, Table 4 ) in mesenteric arteries. The EC 50 value for ACh tended to be elevated in A-CRF animals vs. controls, although this did not reach statistical significance (Fig. 5A , Table 4 , P ϭ 0.06).
Preincubation with L-NAME or L-NAMEϩindomethacin produced increases in EC 50 , and reductions in E max , for ACh that were not significantly different between A-CRF animals and controls (Table 5) . Thus, there were no significant differences between groups regarding the contributions of nitric oxide and vasodilatory prostaglandins to the endotheliumdependent relaxation produced by ACh.
The contraction rate in response to KCl was significantly reduced in mesenteric arteries of A-CRF animals compared with controls (Table 6 ). However, the AUC for the initial 50% reduction in force following washout of KCl was not significantly different between groups, indicating a normal relaxation rate in mesenteric arteries of A-CRF animals ( Table 7) .
Concentration-Response Relations in Intact Thoracic Aortas
Media thickness and media thickness-to-lumen ratio of thoracic aortas were significantly increased in A-CRF animals compared with controls (Table 3) . Maximal wall tension generated by PE and KPSS was not significantly different between groups, but maximal media stress produced by these vasoconstrictors was significantly reduced in A-CRF animals mainly as a consequence of the increase in media thickness (Table 3) . There were no statistically significant differences between groups in EC 50 and E max for PE (Fig. 4B, Table 4 ). The concentration-response relations for ACh and SNP were not significantly altered in A-CRF animals compared with controls (Fig. 5, C and D, Table 4 ).
Rates of Contraction and Relaxation in Intact Thoracic Aortas
A-CRF aortas exhibited a significantly reduced rate of contraction to KCl vs. controls (Table 6 ). In addition, contraction rates in response to 100 nM PE were reduced in A-CRF animals (0.28 Ϯ 0.06 vs. 0.39 Ϯ 0.16 mN/s, P Ͻ 0.05).
The rate of aortic relaxation following washout of KCl was markedly reduced in A-CRF animals, and the AUC for the initial 50% reduction in force was elevated approximately fourfold in A-CRF animals vs. controls (Fig. 6, Table 7 ). The time to achieve a 50% reduction in force following washout of KCl was 346 Ϯ 37 vs. 83 Ϯ 11 s, in A-CRF and controls, respectively, P Ͻ 0.001. The rate of aortic relaxation in response to ACh and SNP in PE precontracted vessels was reduced in A-CRF animals, and AUCs for the initial 50% reduction in force were significantly elevated vs. controls (Table 7) . The relative increases in AUC observed in A-CRF animals vs. controls in response to ACh (ϩ39 Ϯ 37% vs. controls) and SNP (ϩ27 Ϯ 26% vs. controls) were similar and not significantly different. However, the relative increases in AUC in A-CRF animals vs. controls in response to vasodilator agonists ACh and SNP were much less pronounced than those observed after washout of KCl (P Ͻ 0.001).
Rates of Contraction and Relaxation in Endothelium-Denuded Thoracic Aortas
Similar to what was observed in intact aortas, endotheliumdenuded aortas from A-CRF animals showed significantly reduced contraction rates in response to KCl (Table 6 ). The Values are expressed as means Ϯ SD. Media thickness, media-to-lumen radius ratio, wall tension, and media stress were measured and calculated as described in METHODS. Maximal wall tension and media stress in response to noradrenaline (NA), phenylephrine (PE), and KCl (125 mM, KPSS) are presented. A-CRF, adenine-induced chronic renal failure. n ϭ 9 -13 per group. Significant differences, *P Ͻ 0.05, ** P Ͻ 0.01, and ***P Ͻ 0.001. Fig. 3 . Plasma creatinine levels at weeks 2, 4, and 6 after study start in A-CRF animals (n ϭ 7) and controls (n ϭ 7). Blood was collected from tail veins. ***P Ͻ 0.001 between groups. Values are expressed as means Ϯ SD. AUC for the initial 50% reduction in force following washout of KCl was markedly elevated in A-CRF animals vs. controls (Table 7 ). The magnitudes of the reductions in contraction and relaxation rates in endothelium-denuded aortas were not significantly different from those observed in intact aortas.
Vascular Compliance
During the normalization procedure, the stepwise stretching of vessels produces an exponential increase in wall tension. There was no statistically significant difference between groups in the normalization coefficient that defines the slope of the exponential relationship between internal circumference and wall tension either in mesenteric arteries (45 Ϯ 10 vs. 40 Ϯ 4 m Ϫ1 in controls and A-CRF, respectively) or in aortas (5.1 Ϯ 0.3 vs. 5.1 Ϯ 0.4 m Ϫ1 in controls and A-CRF, respectively). Similarly, there were no statistically significant differences between groups in the intercept of the exponential curve in either mesenteric arteries or aortas (data not shown). These results indicate that vascular compliance during passive conditions was not significantly altered in A-CRF animals.
Arterial Histology
No calcifications could be detected by von Kossa staining in either mesenteric arteries (n ϭ 11 for A-CRF and n ϭ 10 for controls), or aortas (n ϭ 13 for both groups). Mesenteric arteries from A-CRF animals and controls did not show any histological abnormalities (Fig. 7, A and B) . The medial layer of aortas from 7 out of 13 examined A-CRF animals displayed an abnormal architecture with fragmentation of elastic lamellae and disorganized VSMCs, whereas these abnormalities were absent in aortas from all controls (P Ͻ 0.01, Fig. 7, C and D) . Although the medial changes in A-CRF animals were present throughout the aortic circumference, there were focal areas with a clearly more severe pathology. In these focal areas, the medial layer also appeared thickened (Fig. 7D ). There were no obvious alterations in the intima or adventitia of A-CRF animals.
DISCUSSION
The main finding in the present study was that the thoracic aorta of A-CRF animals showed a markedly reduced rate of relaxation, although steady-state concentration-response relations to vasodilator agonists were unaltered. In addition, mainly, the aorta was affected, and the relaxation rate in mesenteric resistance arteries was not altered. Furthermore, we demonstrated by radiotelemetry recordings of BP that A-CRF animals develop moderate hypertension that was evident after 3 wk of dietary adenine-intake.
Interestingly, both the aorta and mesenteric arteries from A-CRF animals displayed no significant alterations in the sensitivity, or maximal vasodilatory response to ACh or SNP, even though these rats developed severe reductions in GFR, anemia, and abnormalities in mineral metabolism characteristic of uremia. In addition, plasma levels of MDA and 8-OHdG were elevated, indicative of increased lipid peroxidation and oxidative DNA damage, emphasizing the clinical relevance of the model. From measurements of 51 Cr-EDTA clearance, we know that A-CRF animals develop GFR values of about 10% of controls after 2 mo (unpublished observation). In the present study, plasma creatinine levels were approximately doubled in A-CRF animals already 2 wk after randomization. These data undoubtedly demonstrate that A-CRF animals had had pronounced reductions in GFR for at least 4 wk prior to analyses of vascular function. Taken together, our results suggest that reduced GFR per se, and the observed abnormalities in mineral Fig. 4 . Contractility in mesenteric arteries (A) in response to norepinephrine (NE) and in the thoracic aorta (B) in response to phenylephrine (PE). There were no statistically significant differences between groups in EC50 or Emax values (numeric data presented in Table  4 ). Contractile force is expressed in % of the contraction elicited by 125 mM KCl. Data on maximal wall tension and media stress are presented in Table 3 . n ϭ 10 -13 for each group. Values are expressed as means Ϯ SD. Values are expressed as means Ϯ SD. EC50 and Emax were calculated as described in METHODS. SNP, sodium nitroprusside. There were no statistically significant differences between groups. metabolism and enhanced oxidative stress do not directly impair the sensitivity, or maximal vasodilatory responses, to ACh or SNP at least when examined ex vivo. Our results differ from a number of studies in experimental animal models of CKD in which endothelial-dependent or endothelial-independent vasodilatation was impaired (9, 14 -15, 29, 36 -37) . In addition, endothelial dysfunction has been found in vivo in patients with CKD stage 5 (1, 16) . The discrepancy between our results and those from previous animal studies can at least partly be explained by the fact that most investigators have used the model of 5/6 nephrectomy with infarction of twothirds of the remaining kidney by arterial ligation (9, 14 -15, 36 -37) . In these studies, BP was clearly more elevated than in the present study, suggesting that hypertension might be a more important cause of vascular dysfunction than reduced GFR. Along these lines, a recent study in patients with CKD and minimal comorbidity showed that elevated BP, and not reduced GFR, was the major determinant of aortic stiffness and endothelial dysfunction (17) . We cannot rule out that a longer duration of renal insufficiency could have impaired the concentration-response relation to vasodilator agonists in A-CRF animals. However, less pronounced renal insufficiency of a similar duration as in the present study has repeatedly been associated with endothelial dysfunction in the model of 5/6 nephrectomy (9, 14, 36 -37), clearly indicating that differences in the degree, or duration, of renal insufficiency cannot explain Fig. 5 . Endothelial-dependent and endothelial-independent relaxations in mesenteric arteries and thoracic aortas produced by ACh, and sodium nitroprusside (SNP), respectively. Mesenteric arteries (left) were precontracted with NE and aortas (right) with PE (see METHODS). There were no statistically significant differences between groups in EC50 or Emax values (numeric data presented in Table 4 ). n ϭ 9 -11 per group. Values are expressed as means Ϯ SD.
Table 5. Responses to ACh in mesenteric arteries preincubated with L-NAME or L-NAMEϩindomethacin
Controls (n ϭ 8-10) A-CRF (n ϭ 6-10) log EC50, M ⌬ log EC50 vehicle ϩ0.27 Ϯ 0.20 ϩ0.39 Ϯ 0.32 ⌬ log EC50 L-NAME ϩ0.98 Ϯ 0.21 ϩ0.93 Ϯ 0.20 ⌬ log EC50 L-NAMEϩindomethacin ϩ0.99 Ϯ 0.20 ϩ1.00 Ϯ 0.14 Emax, % ⌬Emax vehicle
Data are expressed as means Ϯ SD. Concentration-response curves for ACh were created before (baseline) and after preincubation with either vehicle, the nitric oxide synthase inhibitor L-NAME (300 M) or L-NAME ϩ indomethacin (3 M) for 15 min. Effects of vehicle and drugs are presented as ⌬ log EC50 and ⌬Emax, reflecting the change in these variables compared to baseline. There were no statistically significant differences between controls and animals with A-CRF in any of the drug responses. For mesenteric arteries and intact aortas 125 mM KCl was used and for endothelium-denuded aortas 85 mM KCl. Data on maximal wall tension and media stress are presented in Table 3 . n ϭ 10 or 11 per group for mesenteric arteries, n ϭ 13 in both groups for intact aortas, and n ϭ 6 -8 per group for denuded aortas. *Significant difference, P Ͻ 0.05. the different results. An alternative explanation for the discrepant results could be that in the model of 5/6 nephrectomy, caused by unilateral nephrectomy and contralateral renal infarction by two-thirds, the renin-angiotensin system is activated at least during early development of hypertension (8, 10) , whereas PRA was markedly suppressed in the present study. An explanation for the less pronounced increase in BP in A-CRF animals, compared with in models of reduced renal mass, could be that adenine produces a chronic tubulointerstitial injury with elevated urine output that would attenuate extracellular fluid volume expansion. The suppressed PRA in A-CRF animals could still indicate hypervolemia, although dysfunction of juxtaglomerular cells secondary to the marked tubulointerstitial injury cannot be dismissed as a cause. The increase in plasma aldosterone levels in A-CRF animals in the presence of low PRA was likely explained by the prevailing hyperkalemia.
To our knowledge, arterial functions have been investigated in one previous study in animals with A-CRF although only the aorta was examined (29) . In that study, concentrations of adenine (0.75%) and phosphate in the chow were higher than in the present study, and 0.22% NaCl was added to drinking water. In addition, some animals received calcitriol to produce aortic calcifications. The results showed that both endotheliumdependent and endothelium-independent vasodilation were impaired with no difference between calcified and noncalcified aortas. In accord with the discussion above, we hypothesize that the different results compared with our study could be explained by higher BP levels in the study by Sutliff et al. (29) , although no data on BP were presented. Likely, the combination of a more pronounced reduction in GFR (secondary to elevated adenine content in the chow) and a much higher NaCl intake should have caused more pronounced hypertension than in the present study. However, other mechanisms, such as more severe derangements in mineral metabolism, could also be involved.
The endothelium regulates the tone of adjacent VSMCs mainly by releasing nitric oxide, prostaglandins, and the endothelium-derived hyperpolarizing factor (EDHF). Nitric oxide is more important in conductance arteries, whereas the contribution of EDHF increases as the size of the arteries decreases (23) . As arterial disease may be associated with a shift in the relative contribution of these endothelium-derived vasodilators (7), this issue was addressed in mesenteric arteries in the present study. Mesenteric arteries from controls and A-CRF animals responded similarly to preincubation with L-NAME, or L-NAMEϩindomethacin, indicating a similar contribution of nitric oxide and prostaglandins in the two groups. Hence, considering that the sensitivity to ACh tended to be reduced in mesenteric arteries from A-CRF animals (P ϭ 0.06 vs. controls for EC 50 ), we cannot completely rule out that EDHF-mediated vasodilation was impaired in A-CRF animals. It should be pointed out that our experiments were carried out ex vivo and that endothelial function might be different in vivo. Plasma levels of ADMA, an analog of L-arginine that inhibits nitric oxide synthase (34) , and SDMA that may interfere with nitric oxide synthesis by competing with L-arginine for transmembrane transport (3), were both significantly elevated in A-CRF animals. Hence, nitric oxide deficiency could have contributed to hypertension and endothelial dysfunction in vivo in A-CRF animals.
The major finding in the present study was that aortas from A-CRF animals showed a marked reduction in the rate of relaxation, mainly, in response to washout of KCl. Although the rate of aortic contraction was also significantly reduced in A-CRF animals, this abnormality was much less pronounced than the defect in relaxation rate. To our knowledge, reduced aortic relaxation rate has not previously been described in CKD. Interestingly, mesenteric arteries from A-CRF animals showed similar relaxation rates as controls, indicating that the reduced relaxation rate was specific for the aorta. The rate of aortic relaxation in A-CRF animals was unaffected by endothelium denudation and was significantly reduced also in response to ACh and SNP. Together, these results clearly indicate that the reduction in aortic relaxation rate was independent of the endothelium and most likely caused by abnormalities in VSMCs. Notably, the relative reduction in relaxation rate was more pronounced following washout of KCl than in response to vasodilators ACh and SNP. This difference suggests that the reduced relaxation rate may predominantly be explained by defects in intracellular Ca 2ϩ -handling in VSMCs as relaxation in response to the nitric oxide-cGMP pathway is mainly Ca 2ϩ -independent. We speculate that the reduced aortic relaxation rate may interfere with dynamic Windkessel function and that Fig. 6 . Time course of aortic relaxation after washout of KCl (125 mM) with physiological salt solution (PSS). The rate of relaxation is markedly reduced in A-CRF animals (numeric data on area under the curve are presented in Table  7 ). Values are means and shaded areas represent SD. Values are expressed as means Ϯ SD. The area under the curve (AUC) during relaxation was calculated for the initial 50% reduction in force following washout of KCl with physiological salt solution (see Fig. 6 ). The concentrations of KCl used were 125 mM for mesenteric arteries and intact aortas and 85 mM for endothelium-denuded aortas. In intact aortas, AUCs in response to ACh (10 M) and SNP (1 M) in PE-precontracted vessels were also obtained. n ϭ 6 -13 per group. Significant differences, *P Ͻ 0.05, and ***P Ͻ 0.001.
it may be a cause of increased aortic stiffness in vivo. The fact that both aortic and mesenteric contraction rates were also diminished in A-CRF animals could indicate that there was a general abnormality in the contractile apparatus of VSMCs or in its regulation. However, maximal wall tension in response to alpha-1 adrenergic receptor agonists and KCl was normal both in mesenteric arteries and in the thoracic aorta of A-CRF animals. On the other hand, maximal media stress was significantly reduced in the aorta of A-CRF animals, mainly as a consequence of increased media thickness, indicating that force generation per mass of VSMCs might be reduced. We believe that these data should be interpreted with caution in view of the histological changes in the aortic media of A-CRF animals (see Fig. 7 ). Thus, stereological measurement of the number and volume of VSMCs in the aorta would be required to determine whether force generation of individual VSMCs was actually reduced. Finally, it remains to be elucidated what factors caused the reduced aortic relaxation rate in A-CRF animals. The fact that mesenteric arteries showed normal relaxation rates argues against a circulating factor. Although BP was only modestly increased in A-CRF animals and did not affect the dose-response relation to vasodilator agonists in the aorta, hypertension cannot be ruled out as a cause, and this needs to be investigated further.
In conclusion, in spite of severe renal failure, both mesenteric resistance arteries and the thoracic aorta showed no abnormalities in the sensitivity, or maximal response, to vasodilator agonists. However, the rate of relaxation specifically in the aorta was markedly reduced in A-CRF animals, which might be of pathophysiological importance in the development of aortic stiffness in CKD.
Perspectives and Significance
The majority of patients with CKD die of cardiovascular disease, and the increase in aortic stiffness is a powerful risk factor for death in this patient group. The main finding of the present study was that aortic relaxation rate was markedly reduced in animals with A-CRF at the same time as the sensitivity and maximal response to vasodilator agonists were normal. We speculate that this functional abnormality, which occurred in the absence of aortic calcifications, could contribute to the development of increased aortic stiffness in CKD. The exact mechanisms causing the reduced aortic relaxation rate need to be determined in future experiments, although our results indicate a defect in intracellular Ca 2ϩ -handling in VSMCs. A future therapy targeting this functional abnormality would have the potential to attenuate the development of increased aortic stiffness in patients with CKD.
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